Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy. [electronic resource]
Producer: 20161213Description: 449-60 p. digitalISSN:- 1750-7448
- Animals
- Cancer Vaccines -- immunology
- Clinical Trials as Topic
- Female
- GPI-Linked Proteins -- immunology
- Humans
- Immunotherapy, Adoptive
- Mesothelin
- Mesothelioma -- immunology
- Molecular Targeted Therapy
- Ovarian Neoplasms -- immunology
- Pancreatic Neoplasms -- immunology
- Receptors, Antigen, T-Cell -- genetics
- Recombinant Fusion Proteins -- immunology
- T-Lymphocytes -- physiology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.